Patents by Inventor Claus Ulrich Jessen

Claus Ulrich Jessen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Semi-recombinant preparation of GLP-1 analogues
    Patent number: 9732137
    Abstract: A semi-recombinant method for the production of GLP-1 analogues and derivatives with non-proteogenic amino acids in the N-terminal part combining the use of recombinant expression techniques and chemical peptide synthesis.
    Type: Grant
    Filed: December 22, 2008
    Date of Patent: August 15, 2017
    Assignee: Novo Nordisk A/S
    Inventors: Jesper Færgeman Lau, Asser Sloth Andersen, Paw Bloch, Jesper Lau, Patrick William Garibay, Thomas Kruse, Inga Sig Nielsen Nørby, Claus Ulrich Jessen, Caspar Christensen, Jens Christian Norrild
  • SEMI-RECOMBINANT PREPARATION OF GLP-1 ANALOGUES
    Publication number: 20100317057
    Abstract: A semi-recombinant method for the production of GLP-1 analogues and derivatives with non-proteogenic amino acids in the N-terminal part combining the use of recombinant expression techniques and chemical peptide synthesis.
    Type: Application
    Filed: December 22, 2007
    Publication date: December 16, 2010
    Applicant: NOVO NORDISK A/S
    Inventors: Jesper Faergeman Lau, Asser Sloth Andersen, Paw Bloch, Jesper Lau, Patrick William Garibay, Thomas Kruse, Inga Sig Nielsen Nørby, Claus Ulrich Jessen, Caspar Christensen, Jens Christian Norrild
  • Method for preparing a compound with growth hormone releasing properties
    Patent number: 6784158
    Abstract: A method for preparing a compound of formula I or a salt thereof is disclosed.
    Type: Grant
    Filed: June 3, 1999
    Date of Patent: August 31, 2004
    Assignee: Novo Nordisk A/S
    Inventor: Claus Ulrich Jessen
  • Polymorphic forms of a 4H-thieno[3,2-E]-1,2,4-thiadiazine 1,1-dioxide derivative
    Publication number: 20040054171
    Abstract: The present invention relates to novel polymorphic/pseudopolymorphic forms of 6-Chloro-3-(1-methylcyclopropyl)amino-4H-thieno[3,2-e]-1,2,4-thiadiazine 1,1-dioxide or mixtures thereof, their preparation and their use as therapeutic agents.
    Type: Application
    Filed: June 27, 2003
    Publication date: March 18, 2004
    Inventors: Anette Frost Jensen, Finn Broni Junager, Claus Ulrich Jessen, Hanne T efting Kornoe, Peter Palitzsch
  • Salt of (2R,3R,4R)-3,4-dihydroxy-2-hydroxymethylpyrrolidine
    Patent number: 6316489
    Abstract: This invention relates to (2R,3R,4R)-3,4-dihydroxy-2-hydroxymethylpyrrolidine D-tartrate, preparation thereof and use as therapeutic agent.
    Type: Grant
    Filed: March 10, 2000
    Date of Patent: November 13, 2001
    Assignee: Novo Nordisk A/S
    Inventors: Claus Ulrich Jessen, Petra Christine Lugstein
  • Salt forms of (2E)-5-amino-5-methylhex-2-enoic acid N-methyl-N-((1R)-1-(N-methyl-N-((1R)-1-(methylcarbamoyl)-2-phenylethyl)carbamoyl)-2-(2-naphthyl)ethyl)amide
    Patent number: 6281247
    Abstract: The compounds disclosed are salts of (2E)-5-amino-5-methylhex-2-enoic acid N-methyl-N-((1R)-1-(N-methyl-N-((1R)-1-(methylcarbamoyl)-2-phenylethyl)carbamoyl)-2-(2-naphthyl)ethyl)amide of Formula I which have an aqueous solubility of at least 5 mg/ml, and a hygroscopicity of less than about 8 at 98% RH. These compounds are useful in the treatment of growth hormone deficiency.
    Type: Grant
    Filed: February 23, 1999
    Date of Patent: August 28, 2001
    Assignee: Novo Nordisk A/S
    Inventor: Claus Ulrich Jessen
  • Salt of (2R,3R,4R)-3,4-dihydroxy-2-hydroxymethylpyrrolidine
    Patent number: 6239163
    Abstract: A new salt of (2R,3R,4R)-3,4-dihydroxy-2-hyroxymethylpyrrolidine is disclosed. Specifically, (2R,3R,4R-3,4-dihydroxy-2-hydroxymethylpyrrolidine, 2-naphthalenesulfonate is disclosed, as well as its preparation and use for treating and preventing diabetes and obesity and for regulating appetite. This salt is characterized as having a high melting point and low hygroscopicity.
    Type: Grant
    Filed: March 10, 2000
    Date of Patent: May 29, 2001
    Assignee: Novo Nordisk A/S
    Inventors: Claus Ulrich Jessen, Petra Christine Lugstein